Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Injectable borax-loaded alginate hydrogels reduce muscle atrophy, modulate inflammation, and promote neuroprotection in the SOD1G93A mouse model of ALS through mechanisms involving IGF-Akt-mTOR signaling

  • Rodriguez-Romano, Ana
  • González-Valdivieso, Juan
  • Moreno-Martínez, Laura
  • Vazquez Costa, Juan Francisco
  • Osta, Rosario
  • Rico Tortosa, Patricia María
[EN] Amyotrophic Lateral Sclerosis (ALS) is a prevalent condition characterized by motor neuron loss and skeletal muscle paralysis. Despite being associated to mutations in over 40 genes, its etiology remains elusive without a cure or effective treatment. ALS, historically considered a motor neuron disease, is defined today as a multisystem disorder involving non-neuronal cell types, including early muscle pathology independent of motor neuron degeneration (dying back hypothesis), thus skeletal muscle actively contributes to disease pathology, making it a viable therapeutic target for ALS. Our previous research has shown that boron transporter NaBC1 (encoded by the SLC4A11 gene), after activation co-localizes with integrins and growth factor receptors synergistically enhancing muscle repair. Here we investigate the effects of injectable alginate-based hydrogels for controlled local borax release in Amyotrophic Lateral Sclerosis muscle. Treated mice showed improved motor function, prolonged survival, and activation of essential muscle metabolic pathways, leading to enhanced muscle repair and reduced atrophy and inflammation. Interestingly, local muscle repair activation provided retrograde neuroprotection by preserving motor neurons and reducing neuro-inflammation. This study highlights the role of muscle tissue in ALS pathology, supporting its targeting with NaBC1-based therapies for muscle regeneration., PR acknowledges support by grant PID2021-126012OB-I00 funded by MCIN/AEI/10.13039/501100011033/and by ERDF a way of making Europe, and by CIBER (CB06/01/1026). JGV acknowledges the funding from the European Union-NextGenerationEU and ARISTOS (European Union's Horizon Europe research and innovation programme under the MSCA grant agreement 101081334) programs. PR acknowledges gratefully the charitable funding provided by the ALS patient LEP and her family and the help provided by CGR, JVH, and PMN.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Age-dependent effect of environmental enrichment on the neural 3D chromatin interactome

  • Gancedo-Verdejo, Javier
  • Urdinguio, Rocío G.
  • Tejedor, Juan Ramón
  • Pérez, Raúl F.
  • Peñarroya, Alfonso
  • Santamarina-Ojeda, Pablo
  • Roberti, Annalisa
  • Kefauver, Jennifer M.
  • Álvarez Díaz, Carlota
  • Rodríguez-Santamaría, Mar
  • Trejo, José L.
  • Tomás Daza, Laureano
  • Rovirosa, Llorenç
  • Javierre, Biola M.
  • Fernández, Agustín F.
  • Fraga, Mario F.
Aging is a multifactorial biological process resulting in physiological and cellular decline. However, our understanding of age-related changes in 3D genome organization and the effect of external interventions on this process remains limited. Here, we describe alterations in the landscape of the 3D chromatin interactome upon aging, utilizing the low-input promoter capture Hi-C (liCHi-C) technique with mouse hippocampal neurons. We also integrated liCHi-C data with RNA sequencing (RNA-seq) data to identify functional implications. Furthermore, we assessed the effect of exposure to environmental enrichment (EE). Remarkably, our results demonstrate an age-dependent modulation of promoter interactions and expression with EE, with aging-like changes induced in young mice upon EE, likely associated with brain maturation, while age-related alterations were reverted in old mice, leading to a partial rejuvenation of aged mouse hippocampi. These findings reveal a dynamic behavior of the neuronal 3D chromatin structure over time, which can be modulated by external interventions., We are grateful to the Scientific and Technical Services (STSs) of the University of Oviedo, including the animal facilities of the University of Oviedo, and especially to Ana Cristina Salas Bustamante for her positive contribution to the project. This work has been funded by Instituto de Salud Carlos III (ISCIII) (grants PI21/01067 and PI24/00641 to M.F.F. and A.F.F.) and co-funded by the European Union, the Spanish Association against Cancer (Fundación científica de la AECC) (PRYGN235109FERN to M.F.F.), the Asturias government (PCTI) co-funding 2018–2023/Fondo Europeo de Desarrollo Regional (FEDER) from the European Union (IDI/2021/000077 and IDI/2024/000744 to M.F.F.), Spanish Biomedical Research Network in Rare Diseases (CIBERER) Acciones Cooperativas y Complementarias Intramurales (ACCI20-34-U766 to M.F.F.), Health Research Institute of the Principality of Asturias (ISPA) and the Asociación Galbán (2021-052-INTRAMUR GALBAN-GOURR to R.G.U. and 2023-165-GALBAN-TEVAJ to J.R.T.), ISPA-Jannsen (2021-048-INTRAMURAL NOV-TEVAR to J.R.T.), the eprObes project funded by the European Union through the Horizon Europe Framework Programme (GA 101080219), and ERA-NET TRANSCAN-3 initiative (JTC 2023) (AC24/00163 to M.F.F.). The laboratory of B.M.J. is supported by FEDER/Spanish Ministry of Science and Innovation (PID2021-125277OB-I00). J.G.-V. is supported by the Spanish Ministry of Universities (FPU20/04659). R.G.U. is supported by the Centro de Investigación Biomédica en Red (CIBER). J.R.T. is supported by a Ramon y Cajal contract from the Spanish Ministry of Science and Innovation (RYC2021-031799-I). R.F.P. (BP17-114) and P.S.-O. (BP17-165) are supported by the Severo Ochoa program. A.R. is supported by the Spanish National Research Council (CSIC) (SOLAUT_00038505 SGL2103040) and eprObes project (GA 101080219). J.M.K. is supported by an ARISTOS fellowship (ARISTOS has received funding from the European Union’s Horizon Europe Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement no. 101081334). L.T.-D. is supported by the FPI Fellowship (PRE2019-088005). L.R. is supported by an AGAUR FI fellowship (2019FI-B00017). B.M.J. is supported by the Instituto de Salud Carlos III (ISCIII) (CP22/00127). We also acknowledge support from the Institute of Oncology of Asturias (IUOPA, supported by Obra Social Cajastur Liberbank, Spain), the Health Research Institute of Asturias (ISPA-FINBA), and Consorcio Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER-ISCIII)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Magnetic field-guided enhancement of nanoparticle uptake and hyperthermia efficacy in 3D tumour models

  • Beola, Lilianne
  • Gutiérrez, Lucía
  • Fratila, Raluca M.
  • de la Fuente, Jesús M.
  • Asín, Laura
  • Grazú, Valeria
Magnetic hyperthermia (MH) using iron oxide nanoparticles (MNPs) is a promising cancer treatment strategy, yet its efficacy strongly depends on efficient intracellular nanoparticle delivery. Here, we compared two strategies to enhance MNP uptake by tumour cells: (i) increasing the administered MNP dose and (ii) applying a static magnetic field (MF) gradient to promote nanoparticle-cell interactions and increase availability at the cell surface. Human tumour cell lines, representing distinct challenges for nanoparticle internalisation due to differences in growth behaviour and cellular organisation, were first incubated with glucose-functionalised 11 nm MNPs under two-dimensional (2D) culture conditions to control and quantify intracellular uptake under each strategy. Cells with pre-internalised MNPs were then embedded in collagen-based three-dimensional (3D) tumour models, where MH was applied and therapeutic efficacy was evaluated by confocal microscopy and flow cytometry. While both strategies increased intracellular MNP levels, only MF-assisted internalisation resulted in effective MH-induced cytotoxicity under mild conditions across all tested cell lines. These findings indicate that antitumour MH efficacy is not solely determined by nanoparticle uptake, but also by the strategy used to enhance internalisation, revealing an additional layer of complexity for designing efficient MH protocols.